Type | Journal Article - Malaria journal |
Title | The challenge of using intermittent preventive therapy with sulfadoxine/pyrimethamine among pregnant women in Uganda |
Author(s) | |
Volume | 15 |
Issue | 1 |
Publication (Day/Month/Year) | 2016 |
URL | https://malariajournal.biomedcentral.com/articles/10.1186/s12936-016-1462-8 |
Abstract | Malaria is hyper-endemic in over 90 % of Uganda’s regions [1] and, therefore, still remains a disease of public health importance. The greatest burden of this disease is born by populations who have either not yet acquired full immunity to malaria, like children under 5 years, or those whose immunity has been suppressed, for example by physiological conditions like pregnancy among women [1, 2]. The National Malaria Control Programme recognizes the significance of increasing the coverage of the most important malaria control interventions and use especially in these two vulnerable populations. In the past decade, with increasing funding, there has been a scale-up of interventions especially on LLIN coverage, case management, and intermittent preventive therapy in pregnant women (IPTp) using sulfadoxine/pyrimethamine (SP). Such efforts have included the shift to universal LLIN coverage [1, 3], with a mass campaign in 2013, increasing availability of rapid diagnostic tools (RDTs) and artemisinin-based combination therapy (ACT) at health facilities for case management and IPTp using SP among pregnant mothers at the ante-natal clinics(ANC) [1]. The national guidelines recommend at least four ANC visits for all pregnant mothers in line with the WHO guidelines [4, 5], where they receive an LLIN on their first visit, and also take SP at each of the visits [6]. |
» | Uganda - Malaria Indicator Survey 2014-2015 |